Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix/Influsplit 2012/2013 Immunogenicity and Safety Study
NCT01607112Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2012
- Primary completion
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Fluarix in influenza, sponsored by GSK. Started Jul 2012; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01607112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01607112.